Digostics Launches University Trial for At-home Type 1 Diabetes Test
July 18, 2025
Pioneering Study Aims to Validate Convenient, Early Detection Method for Type 1 Diabetes Outside Clinical Settings
Pioneering Study Aims to Validate Convenient, Early Detection Method for Type 1 Diabetes Outside Clinical Settings
Next-Generation Oscillating System Enhances Precision and Protects Delicate Tissue in Spine and Cranial Procedures
Certification Advances Global Access to Comprehensive Genetic Testing and Precision Medicine Solutions in Europe
UroMems announced that it received FDA investigational device exemption (IDE) approval to begin a first-of-its-kind trial for its smart implant.
MINNEAPOLIS, July 17, 2025 /PRNewswire/ — Saluda Medical, Inc., a pioneer in the development and commercialization of a novel neuromodulation platform designed to transform the lives of patients with chronic neurological conditions, today announced the full commercial launch of EVA, its next-generation sensing technology, in the United States (U.S.). EVA received U.S. Food & Drug Administration (FDA) approval in December 2024 and is compatible with all commercially implanted Evoke® SmartLoop™ System patients.
Johnson & Johnson (NYSE:JNJ) announced today that the FDA granted priority review to a new drug application (NDA) for its TAR-200.
Learn how “robot metabolism” allows machines to take material from their surroundings to “grow” and to “heal.”
Two university hospitals are pioneering new ways to expand lifesaving heart transplants for adults and babies—advances that could help recover would-be heart donations that too often go unused.
A scientific team supported in part by the National Institutes of Health (NIH) has developed a new, ultra-high-resolution brain imaging system that can reconstruct microscopic brain structures that are disrupted in neurological and neuropsychiatric brain disorders.
Duke Health has pioneered a world’s-first technique that could expand the donor pool for pediatric heart transplants in the U.S. by up to 20%—offering new hope to families on the waitlist.